2,4,6-Tris((trimethylsilyl)ethynyl)-1,3,5-triazine, 97%, 5g

(1-ethyl-1H-benzimidazol-2-yl)methanol, 95.0%, 5g

1,2,3-Benzotriazole, min. 99%, for synthesis, 100 g, plastic packaging.

3-Bromo-5-(difluoromethyl)benzonitrile, 98%, 1g

N-Neopentylbut-3-yn-1-amine hydrochloride, 250mg

2,4-Diethyl-1,5-pentanediol (DL- and meso- mixture)>93.0%(GC)25mL

2-(4-Methoxy-1H-indol-3-yl)acetic acid, 97%, 250mg

3-(2-oxopiperidin-1-yl)propanoic acid, 95.0%, 10g

Methyl 3-oxo-cyclohex-1-enecarboxylate, 95.0%, 250mg

Ethyl 3-oxo-3-phenylpropanoate, 95.0%, 500g

3-(1-Methyl-1H-indol-3-yl)propanenitrile, 500mg

2-[3,5-dimethyl-1-(2,2,2-trifluoroethyl)-1h-pyrazol-4-yl]acetic acid, 95%, 5g

4-Nitrobenzyl 2-bromoacetate, 98%, 25g